Therefore, SRC-3 is also associated with non-hormone targeted cancers, such as liver cancer, pancreatic cancer, lung cancer, gastric cancer, colorectal cancer, bladder cancer, etc. This evidence concerns the gene NCOA3 and familial pancreatic carcinoma.